- Home
- ATXG vs RDHL Comparison
ATXG vs RDHL Comparison
Compare ATXG & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATXG | RDHL |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1M | 3.3M |
| IPO Year | 2015 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ATXG | RDHL |
|---|---|---|
| Price | $2.80 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.9K | ★ 819.0K |
| Earning Date | 11-13-2026 | 09-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17,592.31 |
| Revenue Next Year | N/A | $25.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.28 | $0.39 |
| 52 Week High | $9.56 | $1.60 |
Technical Indicators
Market Signals| Indicator | ATXG | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 35.38 |
| Support Level | $2.50 | N/A |
| Resistance Level | $3.88 | $0.71 |
| Average True Range (ATR) | 0.20 | 0.04 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 40.76 | 7.77 |
Price Performance
Historical ComparisonAbout ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services and Consulting. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.